Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM
10.2337/diab.37.6.667 · 1988 · External reference
Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus
10.1056/nejm199211123272005 · 1992 · External reference
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group
10.1001/jama.281.21.2005 · 1999 · External reference
Unresolved reference
2007 · External reference
U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease
10.2337/diabetes.44.11.1249 · 1995 · External reference
Analysis of factors influencing pancreatic β-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure
10.1016/j.diabres.2008.09.010 · 2008 · External reference
C-peptide response to glucagon. A test for the residual β-cell function in diabetes mellitus
10.2337/diabetes.26.7.605 · 1977 · External reference
Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon
10.1007/bf01236316 · 1977 · External reference
Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics
10.1055/s-2007-1018942 · 1982 · External reference
Reproducibility of β-cell function estimates in non-insulin-dependent diabetes mellitus
10.2337/diacare.10.5.558 · 1987 · External reference
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus
10.1111/j.0954-6820.1981.tb09793.x · 1981 · External reference
Plasma C-peptide response during glucagon test as an index for evaluation of insulin requirement in diabetics (in Japanese)
1985 · External reference
C-peptide determination in the choice of treatment in diabetes mellitus
10.3109/00365518509155265 · 1985 · External reference
Indices of urinary and serum C-peptide corrected with fasting plasma glucose for decision-making of insulin therapy in type 2 diabetes-validation and comparison (in Japanese)
2008 · External reference
Diagnosis and classification of diabetes mellitus
10.2337/dc10-s062 · 2010 · External reference
Unresolved reference
1979 · External reference
Standards of medical care in diabetes-2010
10.2337/dc10-s011 · 2010 · External reference
Unresolved reference
2007 · External reference
10.1111/j.2040-1124.2010.00074.x · 2010 · Admitted local publication
SUIT, secretory units of islets in transplantation: an index for therapeutic management of islet transplanted patients and its application to type 2 diabetes
10.1016/j.diabres.2006.03.030 · 2006 · External reference
Unresolved reference
2007 · External reference
Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial
10.1016/s0002-8223(95)00276-6 · 1995 · External reference
A simple meal plan emphasizing healthy food choices is as effective as an exchange-based meal plan for urban African Americans with type 2 diabetes
10.2337/diacare.26.6.1719 · 2003 · External reference
Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial
10.1006/pmed.2001.0985 · 2002 · External reference
Unresolved reference
2007 · External reference
Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus
10.1016/s0168-8227(97)00069-7 · 1997 · External reference
Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes
10.1016/j.diabres.2004.10.005 · 2005 · External reference
The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?
10.1136/bmj.288.6435.1956 · 1984 · External reference
Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients
10.1007/s125-002-8248-z · 2002 · External reference
β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes
10.2337/diabetes.52.1.102 · 2003 · External reference
Pancreatic β-cell mass in European subjects with type 2 diabetes
10.1111/j.1463-1326.2008.00969.x · 2008 · External reference
Functional assessment of pancreatic β-cell area in humans
10.2337/db08-1611 · 2009 · External reference
